Update on vascular tumors of infancy

Current Opinion in Pediatrics

Volumn 22, Issue 4, 2010, Pages 432-437

  Sidbury, Robert ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

hemangioma; kaposiform hemangioendothelioma; PHACE syndrome; propranolol; tufted angioma

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; DEXAMETHASONE; NOTCH RECEPTOR; PLACEBO; PREDNISOLONE; PROPRANOLOL; TIMOLOL; VASODILATOR AGENT;

BLOOD CLOTTING DISORDER; BRADYCARDIA; BRONCHOSPASM; CELL PROLIFERATION; CLINICAL TRIAL; COMPETITIVE INHIBITION; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG DOSE TITRATION; ENDOTHELIUM CELL; EXOPHTHALMOS; EYELID HEMANGIOMA; HEMANGIOMA; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INFANCY; INFANTILE HEMANGIOMA; KAPOSIFORM HEMANGIOENDOTHELIOMA; KASABACH MERRITT SYNDROME; LIVER HEMANGIOMA; MONOTHERAPY; MULTIPLE MALFORMATION SYNDROME; NONHUMAN; PATHOGENESIS; PHACE SYNDROME; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN HEMANGIOMA; THERAPY EFFECT; TUFTED ANGIOMA; ULCER; VASCULAR TUMOR; CANCER STAGING; INFANT; PATHOLOGY; PROCEDURES; UNITED STATES; VASCULAR ENDOTHELIUM; VASCULAR NEOPLASMS;

CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; HUMANS; INFANT; NEOPLASM STAGING; PREVALENCE; PROPRANOLOL; UNITED STATES; VASCULAR NEOPLASMS; VASODILATOR AGENTS;

EID: 77955231316     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32833bb764     Document Type: Review

References (31)

1. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they: a systematic review of the literature. Pediatr Dermatol 2008; 25:168-173.
2. Boye E, Jinnin M, Olsen BR, et al. Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg 2009; 20 (Suppl 1):678-684.
3. Bischoff J. Progenitor cells in infantile hemangioma. J Craniofac Surg 2009; 20 (Suppl 1):695-697.
4. Khan ZA, Boscolo E, Picard E, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008;118:2592-2599.
5. Wu JK, Adepoju O, De Silva D, et al. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis 2010; 13:15-23.
6. Greenberger S, Boscolo E, Adini I, et al. Corticosteroid suppression of VEGFA in infantile hemangioma derived stem cells. N Engl J Med 2010; 362:1005-1013.
7. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118:882-887.
8. Alvarez Connelly E, Viera M, Price C, et al. Segmental hemangioma of infancy complicated by life-threatening arterial bleed. Pediatr Derm 2009; 26:469-472.
9. Chamlin SL, Haggstrom AN, Drolet BA, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr 2007; 151:684-689.
10. Metry DW, Haggstrom AN, Drolet BA, et al. A prospective study of PHACE syndrome in infantile hemangioma: demographic features, clinical findings, and complications. Am J Med Genet 2006; 140:975-986.
11. Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa abnormalities, hemangioma, arterial anomalies, coarctation, eye. Arch Dermatol 1996; 132:307-311.
12. Metry DW, Heyer G, Hess C, et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124:1447-1456.
13. Manunza F, Syed S, Laguda J, et al. Propranolol for complicated infantile hemangiomas: a case series of 30 infants. Br J Dermatol 2010; 162:466-468.
14. Metry DW, Garzon M, Drolet B, et al. PHACE syndrome: current knowledge, future directions. Pediatr Derm 2009; 25:381-398.
15. Dickie B, Dasgupta R, Nair et al. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 2009; 44:125-133.
16. Metry DW, Hawrot A, Altman C, et al. Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 2004; 140:591-596.
17. Hughes JA, Hill V, Patel K, et al. Cutaneous hemangioma: prevalence and sonographic characteristics of associated hepatic hemangiomas. Clin Radiol 2004; 59:273-280.
18. Horii K, Drolet B, Besalga E, et al. Risk of hepatic hemangiomas in infants with large hemangiomas. Arch Dermatol 2010; 146:201-202.
19. Leaute-Labreze C, Dumas de la Roque E, Hubiche B, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358:2649-2651.
20. Truong MT, Chang KW, Bork DR, et al. Propranolol for the treatment of a life-threatening subglottic and mediastinal IH. J Pediatr 2010; 156:335-338.
21. Fay A, Nguyen J, Jakobiec FA, et al. Propranolol for isolated orbital IH. Arch Ophthalmol 2010; 125:256-257.
22. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009; 26:610-614.
23. Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using b-blocker solution. Arch Ophthalmol 2010; 128:255-256.
24. Frieden IJ, Drolet BA. Propranolol for IH: promise, peril, pathogenesis. Pediatr Derm 2009; 26:642-644.
25. Tsang WYW, Chan JKC. Kaposi-like infantile hemangiothelioma: a distinctive vascular neoplasm of the retroperitoneum. Am J Surg Pathol 1991; 15:982-989.
26. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangoendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993; 17:321-328.
27. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach Merritt syndrome do not have 'true' hemangiomas. J Pediatr 1997; 130:631-640.
28. Gruman A, Liang M, Mulliken J, et al. Kaposiform hemangioendothelioma without Kasabach Merritt phenomenon. J Am Acad Dermatol 2005; 92:616-622.
29. San Miguel FL, Spurbeck W, Budding C, Horton J. Kaposiform hemangioendothelioma: a rare cause of spontaneous hemothorax in infancy. J Pediatr Surg 2008; 43:E37-41.
30. Cho W-S, Kim S-K, Park S-H, Cho B-K. Intracranial kaposiform hemangioendothelioma: proposal of a new malignant variant. J Neurosurg Pediatr 2009;3:147-150.
31. Maronn M, Chamlin S, Metry DW. Multifocal tufted angioma in two infants. Arch Dermatol 2009; 145:847-848.